Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 20, 2023
Merkel cell carcinoma researcher Dr. Nick Salisbury named Brave Fellow
Rare skin cancer is focus of work by Fred Hutch scientist who will receive support honoring runner Gabe Grunewald
A cold case reopened for Merkel cell carcinoma
From the Galloway lab, Human Biology Division
DNA repair hijacking by HPV
From the Galloway lab, Human Biology Division
Protection of HIV-1 infected adolescents against HPV-related cancers in Africa
From the Galloway lab, Human Biology Division
Two shots may be better than three
From Erin Scherer and the Galloway lab, Human Biology Division
Nearly half of U.S. men actively infected with HPV, study finds
HPV-linked cancers on the rise in men, but nearly 9 in 10 vaccine-eligible men are unvaccinated
HPV vaccine boosts immune memory
A single dose of the HPV vaccine can strengthen immune memory in people who’ve previously been infected with HPV — and potentially help prevent re-infection
HPV vaccine uptake highest in Hispanic, low-income communities
Where you live matters for cancer-preventing shot, new study suggests
‘It’s been an incredible ride’
Dr. Denise Galloway reflects on a career — and a life — touched by cancer
1 in 10 women is not being screened for cervical cancer
As with the HPV vaccine, a key barrier is 'missed opportunities' among doctors
Finding better ways to treat, prevent HPV
Fred Hutch’s Dr. Denise Galloway chairs gathering of the brightest minds to discuss new advances in HPV research – and what’s still needed
Test for virus that causes cervical cancer should replace Pap, FDA advisors say
FDA committee advises replacing Pap with DNA test for human papillomavirus